Landscapes / Targets
myosin
5 drugs act on myosin, in 12 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Cardiac myosin inhibitor |
Bristol Myers Squibb · Public BMY |
Approved | 13 Dec 2027Phase 4 trial completes | ||
| Next date | 13 Dec 2027 · Phase 4 trial completes | ||||
| Also tested for | Cardiomyopathy, Hypertrophic, Symptomatic Obstructive Hypertrophic Cardiomyopathy and 1 more | ||||
| Open drug page | |||||
— |
Approved | Mar 2029Phase 2/3 trial completes | |||
| Next date | Mar 2029 · Phase 2/3 trial completes | ||||
| Also tested for | Symptomatic Hypertrophic Cardiomyopathy (HCM), Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy and 2 more | ||||
| Open drug page | |||||
— |
Kardigan +1 · Public BMY |
Phase 3 | Sep 2027Phase 2/3 trial completes | ||
| Next date | Sep 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Symptomatic Genetic Dilated Cardiomyopathy, Symptomatic Genetic Dilated Cardiomyopathy (DCM) | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Obstructive Hypertrophic Cardiomyopathy | ||||
| Open drug page | |||||
— |
Phase 1/2 | Mar 2027Phase 1/2 trial completes | |||
| Next date | Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Glioblastoma (GBM), Glioblastoma | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026